Product information
From Health Canada
Current status:
Cancelled Post Market
Current status date:
1998-08-13
Original market date: See footnote 1
1986-12-31
Product name:
FEIBA VH IMMUNO ANTI INHIBITOR
DIN:
00609137 Electronic product monograph is not available
Company:
OSTERREICHISCHES INSTITUT FUR HAEMODERIVATE GES M.B.H.
67 Industriestrasse
Vienna
--
Austria
1221
Class:
Human
Dosage form(s):
Powder For Solution
Route(s) of administration:
Intravenous
Number of active ingredient(s):
5
Schedule(s):
Schedule D
American Hospital Formulary Service (AHFS): See footnote 3
20:28.16
Anatomical Therapeutic Chemical (ATC): See footnote 4
B02BD03 FACTOR VIII INHIBITOR BYPASSING ACTIVITY
Active ingredient group (AIG) number:See footnote5
0516347001
Active ingredient(s) | Strength |
---|---|
ANTIHEMOPHILIC FACTOR (HUMAN) | 4 UNIT / ML |
COAGULATION FACTOR II (HUMAN) | null NIL / ML |
COAGULATION FACTOR VII (HUMAN) | null NIL / ML |
COAGULATION FACTOR X (HUMAN) | null NIL / ML |
FACTOR IX COMPLEX HUMAN | null NIL / ML |